"Market and Product Forecasts: HIV - Rising Prevalence and Novel STRs Boost Sales in the US and Europe" Published
This report explores key issues in HIV across the US and five major EU markets (France, Germany, Italy, Spain, and the UK). It contains an assessment of key HIV drugs, a discussion of HIV market dynamics, and a 10-year patient-based sales forecast.
View full press release